6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
21m ago	Sunrun Prices $584 million Securitization of Residential Solar and Storage Assets
21m ago	Madison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
45m ago	Ultra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
45m ago	GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
45m ago	Rush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend

About

Xbiotech Inc (NASDAQ:XBIT) — investor relations, events, news, and company updates on 6ix.

Latest News

XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer

XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus

XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke

XBiotech Announces Enrollment Completion of Phase II, Placebo Controlled, Multicenter Study for Natrunix in Pancreatic Cancer

XBiotech Announces First Patient Begins Novel Natrunix Therapy in Phase II Rheumatoid Arthritis (RA) Clinical Trial

Financials

Revenue

$300 K

Market Cap

$71.65 M

EPS

-1.49

Community Chat

Ask AI